{"id":"https://openalex.org/W2809392500","doi":"https://doi.org/10.1089/jir.2018.0030","title":"Activity of Anti-CD19 Chimeric Antigen Receptor T Cells Against B Cell Lymphoma Is Enhanced by Antibody-Targeted Interferon-Alpha","display_name":"Activity of Anti-CD19 Chimeric Antigen Receptor T Cells Against B Cell Lymphoma Is Enhanced by Antibody-Targeted Interferon-Alpha","publication_year":2018,"publication_date":"2018-06-01","ids":{"openalex":"https://openalex.org/W2809392500","doi":"https://doi.org/10.1089/jir.2018.0030","mag":"2809392500","pmid":"https://pubmed.ncbi.nlm.nih.gov/29920129","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6007814"},"language":"en","primary_location":{"id":"doi:10.1089/jir.2018.0030","doi":"https://doi.org/10.1089/jir.2018.0030","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jir.2018.0030","pdf_url":null,"source":{"id":"https://openalex.org/S109620152","display_name":"Journal of Interferon & Cytokine Research","issn_l":"1079-9907","issn":["1079-9907","1557-7465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Interferon & Cytokine Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6007814","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000482632","display_name":"Patricia Ann Young","orcid":"https://orcid.org/0000-0002-2161-9377","observed_orcids":["https://orcid.org/0000-0002-2161-9377","https://orcid.org/0000-0001-6698-2949"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia A. Young","raw_affiliation_strings":["Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018823792","display_name":"Reiko E. Yamada","orcid":"https://orcid.org/0000-0002-2680-6972","observed_orcids":["https://orcid.org/0000-0002-2680-6972"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Reiko E. Yamada","raw_affiliation_strings":["Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110785256","display_name":"Kham R. Trinh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kham R. Trinh","raw_affiliation_strings":["Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005160594","display_name":"Alex Vasuthasawat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Vasuthasawat","raw_affiliation_strings":["Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031879484","display_name":"Satiro Nakamura De Oliveira","orcid":"https://orcid.org/0000-0002-8181-7316","observed_orcids":["https://orcid.org/0000-0002-8181-7316"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Satiro De Oliveira","raw_affiliation_strings":["Division of Pediatric Hematology & Oncology, Department of Pediatrics, University of California, Los Angeles, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pediatric Hematology & Oncology, Department of Pediatrics, University of California, Los Angeles, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046877251","display_name":"Douglas H. Yamada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas H. Yamada","raw_affiliation_strings":["Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113503188","display_name":"Sherie Leaver Morrison","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sherie L. Morrison","raw_affiliation_strings":["Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107833759","display_name":"John M. Timmerman","orcid":"https://orcid.org/0000-0003-4104-8943","observed_orcids":["https://orcid.org/0000-0003-4104-8943"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John M. Timmerman","raw_affiliation_strings":["Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5107833759"],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":null,"apc_paid":null,"fwci":0.4689,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.66576819,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"38","issue":"6","first_page":"239","last_page":"254"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.9200000166893005},{"id":"https://openalex.org/keywords/cd19-car-t-cell-therapy","display_name":"CD19 CAR T-cell therapy","score":0.9419999718666077},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.9679999947547913},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.9110000133514404},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.6510000228881836},{"id":"https://openalex.org/keywords/cytokine-production","display_name":"cytokine production","score":0.6779999732971191},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.42899999022483826},{"id":"https://openalex.org/keywords/tumor-cell-killing","display_name":"tumor cell killing","score":0.5540000200271606}],"concepts":[{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.7914777994155884},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.6689854264259338},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.572766900062561},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5378244519233704},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4909403622150421},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4877048432826996},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4749312996864319},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.446336567401886},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.4408641755580902},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.44060981273651123},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4165731966495514},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.41565632820129395},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.41142675280570984},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.323056161403656},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.30943113565444946}],"mesh":[{"descriptor_ui":"D000076962","descriptor_name":"Receptors, Chimeric Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000937","descriptor_name":"Antigen-Antibody Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018941","descriptor_name":"Antigens, CD19","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1089/jir.2018.0030","doi":"https://doi.org/10.1089/jir.2018.0030","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jir.2018.0030","pdf_url":null,"source":{"id":"https://openalex.org/S109620152","display_name":"Journal of Interferon & Cytokine Research","issn_l":"1079-9907","issn":["1079-9907","1557-7465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Interferon & Cytokine Research","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6007814","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6007814","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Interferon Cytokine Res","raw_type":"Text"},{"id":"pmid:29920129","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29920129","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research","raw_type":"Journal Article"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt9m7954vw","doi":null,"is_oa":false,"landing_page_url":"https://escholarship.org/uc/item/9m7954vw","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Interferon & Cytokine Research, vol 38, iss 6","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:6007814","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6007814","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Interferon Cytokine Res","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4673888999","display_name":"Engineering Precision Medicine to Enhance Graft-Versus-Lymphoma Effect","funder_award_id":"K23CA222659","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4677202866","display_name":null,"funder_award_id":"TRTH30","funder_id":"https://openalex.org/F4320310646","funder_display_name":"European Hematology Association"},{"id":"https://openalex.org/G5310651434","display_name":"Anti-CD138-IFN fusion proteins for the immunotherapy of multiple myeloma","funder_award_id":"R01CA200910","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6636428648","display_name":"Antibody-interferon fusion proteins for treatment of B-cell malignancies","funder_award_id":"R01CA162964","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7811902380","display_name":"UCLA Center for AIDS Research (CFAR)","funder_award_id":"P30AI028697","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320310646","display_name":"European Hematology Association","ror":"https://ror.org/05hk0hn26"},{"id":"https://openalex.org/F4320311591","display_name":"Tower Cancer Research Foundation","ror":"https://ror.org/04bfv0919"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W1611944043","https://openalex.org/W1686812758","https://openalex.org/W1967475015","https://openalex.org/W1994594038","https://openalex.org/W2014358640","https://openalex.org/W2019359568","https://openalex.org/W2042108891","https://openalex.org/W2047742947","https://openalex.org/W2055746114","https://openalex.org/W2067753430","https://openalex.org/W2072158757","https://openalex.org/W2082708772","https://openalex.org/W2086390390","https://openalex.org/W2093762704","https://openalex.org/W2099570622","https://openalex.org/W2099805214","https://openalex.org/W2111785254","https://openalex.org/W2115091768","https://openalex.org/W2130338247","https://openalex.org/W2142115645","https://openalex.org/W2144697790","https://openalex.org/W2145985838","https://openalex.org/W2154534003","https://openalex.org/W2154853638","https://openalex.org/W2161958391","https://openalex.org/W2165984958","https://openalex.org/W2170513194","https://openalex.org/W2275249553","https://openalex.org/W2317584385","https://openalex.org/W2509364267","https://openalex.org/W2568453485","https://openalex.org/W2623114472","https://openalex.org/W2751422538","https://openalex.org/W2773804840"],"related_works":["https://openalex.org/W2305855934","https://openalex.org/W2042108891","https://openalex.org/W4410457136","https://openalex.org/W2983983259","https://openalex.org/W4405126173","https://openalex.org/W2563087865","https://openalex.org/W6989921366","https://openalex.org/W2618705717","https://openalex.org/W2086390390","https://openalex.org/W2055585595"],"abstract_inverted_index":{"An":[0],"important":[1,187],"emerging":[2],"form":[3],"of":[4,22,34,58,82,112,121,157,160,166,176,194],"immunotherapy":[5],"targeting":[6],"B":[7,29,114,133],"cell":[8,16,26,30,43,63,68,115,130,134,140,161,197],"malignancies":[9],"is":[10,49],"chimeric":[11],"antigen":[12],"receptor":[13],"(CAR)":[14],"T":[15,25,42,62,85,125,151,169,196],"therapy.":[17,198],"Despite":[18],"encouraging":[19],"response":[20,35],"rates":[21],"anti-CD19":[23,83],"CAR":[24,41,84,124,150,168,195],"therapy":[27,48],"in":[28,53,173],"lymphomas,":[31],"limited":[32],"durability":[33],"necessitates":[36],"further":[37],"study":[38],"to":[39,60,106,190],"potentiate":[40],"efficacy.":[44],"Antibody-targeted":[45],"interferon":[46],"(IFN)":[47],"a":[50],"novel":[51,188],"approach":[52,189],"immunotherapy.":[54],"Given":[55],"the":[56,79,94,119,145,158,174,192],"ability":[57,105],"IFNs":[59],"promote":[61],"activation":[64],"and":[65,70,102,109,123],"survival,":[66],"target":[67],"recognition,":[69],"cytotoxicity,":[71],"we":[72,127],"asked":[73],"whether":[74],"antibody-targeted":[75,182],"IFN":[76,98,183],"could":[77],"enhance":[78],"antitumor":[80],"effects":[81],"cells.":[86],"We":[87],"produced":[88],"an":[89,186],"anti-CD20-IFN":[90],"fusion":[91],"protein":[92],"containing":[93],"potent":[95],"type":[96],"1":[97],"isoform":[99],"alpha14":[100],"(\u03b114),":[101],"demonstrated":[103],"its":[104],"suppress":[107],"proliferation":[108],"induce":[110],"apoptosis":[111],"human":[113],"lymphomas.":[116],"Indeed,":[117],"with":[118,143],"combination":[120],"anti-CD20-hIFN\u03b114":[122],"cells,":[126],"found":[128],"enhanced":[129,172],"killing":[131],"among":[132],"lymphoma":[135],"lines.":[136],"Importantly,":[137],"for":[138],"all":[139],"lines":[141],"pretreated":[142],"anti-CD20-hIFN\u03b114,":[144],"subsequent":[146],"cytokine":[147],"production":[148],"by":[149],"cells":[152,170],"was":[153],"markedly":[154],"increased":[155],"regardless":[156],"degree":[159],"killing.":[162],"Thus,":[163],"several":[164],"activities":[165],"CD19":[167],"were":[171],"presence":[175],"anti-CD20-hIFN\u03b114.":[177],"These":[178],"data":[179],"suggest":[180],"that":[181],"may":[184],"be":[185],"improving":[191],"efficacy":[193]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-06-29T00:00:00"}